|
|
|
|
LEADER |
00000pam a22000004a 4500 |
001 |
6101148 |
003 |
ICU |
005 |
20080103114300.0 |
008 |
051129s2006 njua b 001 0 eng |
010 |
|
|
|a 2005034845
|
020 |
|
|
|a 1588296245 (alk. paper)
|
020 |
|
|
|a 9781588296245
|
040 |
|
|
|a DNLM/DLC
|c DLC
|d NLM
|d BAKER
|d C#P
|d NhCcYBP
|d UtOrBLW
|d OrLoB-B
|
042 |
|
|
|a pcc
|
050 |
0 |
0 |
|a RC918.D53
|b D522 2006
|
060 |
1 |
0 |
|a WK 835
|b D5358 2006
|
082 |
0 |
0 |
|a 616.6/1
|2 22
|
245 |
0 |
4 |
|a The diabetic kidney /
|c edited by Pedro Cortes, Carl Erik Mogensen.
|
260 |
|
|
|a Totowa, N.J. :
|b Humana Press,
|c c2006.
|
300 |
|
|
|a xviii, 564 p. :
|b ill. ;
|c 27 cm.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
440 |
|
0 |
|a Contemporary diabetes
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g 1.
|t Angiotensin II and its receptors in the pathogenesis of diabetic nephropathy /
|r David J. Leehey, Ashok K. Singh and Rekha Singh --
|g 2.
|t Altered renal microvascular function in early diabetes /
|r Pamela K. Carmines, Joseph P. Bast and Naohito Ishii --
|g 3.
|t Proteinuria and interstitial fibrogenesis in diabetic nephropathy /
|r Raimund Hirschberg --
|g 4.
|t Podocytes and diabetic nephropathy /
|r George Jerums, Sianna Panagiotopoulos and Richard MacIsaac --
|g 5.
|t Altered glucose transport and its metabolic effects in glomerular cells /
|r Charles W. Heilig --
|g 6.
|t mRNA translation in diabetic nephropathy /
|r Balakuntalam S. Kasinath, Myung Ja Lee, Denis Feliers and Nahum Sonenberg --
|g 7.
|t The hexosamine biosynthesis pathway : contribution to the pathogenesis of diabetic nephropathy /
|r I. George Fantus, Howard J. Goldberg, Catharine I. Whiteside and Delilah Topic --
|g 8.
|t Glycation : receptor for advanced glycation endproducts and diabetic nephropathy /
|r Vivette D'Agati and Ann Marie Schmidt --
|g 9.
|t Oxidative and glycooxidative stress in diabetic nephropathy /
|r Frederick R. DeRubertis and Patricia A. Craven --
|g 10.
|t Connective tissue growth factor in the pathogenesis of diabetic nephropathy : a target for therapeutic intervention /
|r Bruce L. Riser, Alessia Fornoni and Sujatha Karoor --
|g 11.
|t Vascular endothelial growth factor as a determinant of diabetic nephropathy /
|r Geoffrey Boner and Mark E. Cooper --
|g 12.
|t Transforming Growth factor-[beta] signal transduction in the pathogenesis of diabetic nephropathy : identifying molecular targets for therapeutic intervention /
|r Sheldon Chen and Fuad N. Ziyadeh --
|g 13.
|t Hepatocyte growth factor : physiological and therapeutic ligand to attenuate diabetic nephropathy /
|r Shinya Mizuno and Toshikazu Nakamura --
|g 14.
|t Proteomics in the investigation of diabetic nephropathy /
|r Visith Thongboonkerd --
|g 15.
|t Gene expression profiling in the investigation of diabetic nephropathy /
|r Katalin Susztak, Erwin Bottinger and Kumar Sharma --
|g 16.
|t PPAR-[gamma] ligands and diabetic nephropathy /
|r Keiji Isshiki, Daisuke Koya and Masakazu Haneda --
|g 17.
|t [alpha]-endosulfine in diabetic nephropathy /
|r Jerry Yee and Balazs Szamosfalvi --
|g 18.
|t The prospect of a novel therapeutic, bone morphogenetic protein-7, in diabetic nephropathy /
|r Keith A. Hruska, Laura DePetris, Tingting Li, Song Wang, Theresa Geurs, Frank Strebeck, Qing Chen and Helen Liapis --
|g 19.
|t Genetic determinants of diabetic nephropathy in type 2 diabetes /
|r Grzegorz Placha and Andrzej S. Krolewski --
|g 20.
|t Major risk indicators for diabetic kidney disease /
|r Katherine R. Tuttle --
|g 21.
|t The structure of human diabetic nephropathy /
|r Michael Mauer and Behzad Najafian --
|g 22.
|t Diabetic kidney disease in transitional and disadvantaged populations /
|r E. Jennifer Weil and Robert G. Nelson --
|g 23.
|t Screening and treatment of early diabetic renal disease in type 1 and type 2 diabetes /
|r Ellie Chuang and Mark E. Molitch --
|g 24.
|t Treatment in advanced renal disease in type 1 and type 2 diabetes /
|r Eberhard Ritz and Gunter Wolf --
|g 25.
|t Diabetic and renal disease : ACE inhibitors and/or angiotensin receptor blockers : does it matter? /
|r Carl Erik Mogensen and Niels Holmark Andersen --
|g 26.
|t Management of diabetic end-stage renal disease with dialysis /
|r Ploumis S. Passadakis and Dimitrios G. Oreopoulos --
|g 27.
|t Diabetic retinopathy and nephropathy /
|r Ronald Klein --
|g 28.
|t Hypertension and cardiovascular disease /
|r Adam Whaley-Connell, Kurt Sowers and James R. Sowers --
|g 29.
|t Endothelial dysfunction and diabetic nephropathy /
|r Coen D. A. Stehouwer, Maya S. P. Huijberts, Alfons J. H. M. Houben and Nicolaas C. Schaper --
|g 30.
|t Anemia and diabetic nephropathy /
|r George Jerums, Richard MacIsaac, Sianna Panagiotopoulos and Merlin Thomas.
|
650 |
|
0 |
|a Diabetic nephropathies.
|0 http://id.loc.gov/authorities/subjects/sh85037470
|
650 |
|
0 |
|a Diabetes.
|0 http://id.loc.gov/authorities/subjects/sh85037456
|
650 |
1 |
2 |
|a Diabetic Nephropathies
|x physiopathology.
|
650 |
2 |
2 |
|a Diabetes Mellitus
|x diagnosis.
|
650 |
2 |
2 |
|a Diabetes Mellitus
|x therapy.
|
650 |
|
7 |
|a Diabetes.
|2 fast
|0 http://id.worldcat.org/fast/fst00892147
|
650 |
|
7 |
|a Diabetic nephropathies.
|2 fast
|0 http://id.worldcat.org/fast/fst00892229
|
700 |
1 |
|
|a Cortes, Pedro.
|0 http://id.loc.gov/authorities/names/n2005184862
|1 http://viaf.org/viaf/64312938
|
700 |
1 |
|
|a Mogensen, Carl Erik.
|0 http://id.loc.gov/authorities/names/n85273185
|1 http://viaf.org/viaf/42007393
|
901 |
|
|
|a ToCBNA
|
903 |
|
|
|a HeVa
|
035 |
|
|
|a (OCoLC)62509127
|
929 |
|
|
|a cat
|
999 |
f |
f |
|i 477f12c0-1418-5813-bf04-f265e381de3c
|s 30efcb3d-7c22-5db4-986f-ea3cda5ac5b1
|
928 |
|
|
|t Library of Congress classification
|a RC918.D53 D522 2006
|l ASR
|c ASR-SciASR
|i 5114866
|
927 |
|
|
|t Library of Congress classification
|a RC918.D53 D522 2006
|l ASR
|c ASR-SciASR
|e BELF
|e CRERAR
|b 75392331
|i 8062232
|